Zimmer Biomet Holdings Inc
ZBH99.560USD
-0.150-0.15%
Handelsschluss 10/30, 16:00（ET）Kurse um 15 Minuten verzögert
19.70BMarktkapitalisierung
23.93KGV TTM
mehr Informationen über Zimmer Biomet Holdings Inc Unternehmen
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; biologics, sports medicine, extremities and trauma (S.E.T.) products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and ankle, among others.
Zimmer Biomet Holdings Inc Informationen
BörsenkürzelZBH
Name des UnternehmensZimmer Biomet Holdings Inc
IPO-datumJul 25, 2001
CEOMr. Ivan Tornos
Anzahl der mitarbeiter17000
WertpapierartOrdinary Share
GeschäftsjahresendeJul 25
Addresse345 E Main St
StadtWARSAW
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl46580-2746
Telefon15742676131
Websitehttps://www.zimmerbiomet.com/en
BörsenkürzelZBH
IPO-datumJul 25, 2001
CEOMr. Ivan Tornos
Führungskräfte von Zimmer Biomet Holdings Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
48.85K
+5.46%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
18.42K
-6.11%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
6.79K
-18.09%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Mr. Syed A. Jafry
Mr. Syed A. Jafry
Independent Director
Independent Director
4.06K
--
Mr. Robert A. Hagemann
Mr. Robert A. Hagemann
Independent Director
Independent Director
4.00K
--
Mr. Paul A. Stellato
Mr. Paul A. Stellato
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
3.42K
+34.66%
Mr. Arthur J. (Art) Higgins
Mr. Arthur J. (Art) Higgins
Independent Director
Independent Director
3.40K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
48.85K
+5.46%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
18.42K
-6.11%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
6.79K
-18.09%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Knees
826.00M
39.76%
S E T
550.60M
26.51%
Hips
536.10M
25.81%
Other product category
164.60M
7.92%
Nach RegionUSD
Name
Umsatz
Anteil
United States
1.17B
56.51%
International
903.50M
43.49%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Knees
826.00M
39.76%
S E T
550.60M
26.51%
Hips
536.10M
25.81%
Other product category
164.60M
7.92%
Aktionärsstatistik
Aktualisiert: Tue, Aug 19
Aktualisiert: Tue, Aug 19
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.69%
Dodge & Cox
11.15%
T. Rowe Price Associates, Inc.
7.32%
BlackRock Institutional Trust Company, N.A.
5.52%
State Street Investment Management (US)
4.42%
Andere
59.90%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.69%
Dodge & Cox
11.15%
T. Rowe Price Associates, Inc.
7.32%
BlackRock Institutional Trust Company, N.A.
5.52%
State Street Investment Management (US)
4.42%
Andere
59.90%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
52.70%
Investment Advisor/Hedge Fund
37.54%
Pension Fund
2.02%
Hedge Fund
1.78%
Research Firm
1.76%
Sovereign Wealth Fund
1.31%
Bank and Trust
1.28%
Individual Investor
0.13%
Family Office
0.07%
Andere
1.41%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
1921
195.80M
98.84%
-775.88K
2025Q2
1996
190.39M
96.22%
-5.04M
2025Q1
2047
189.51M
95.78%
-9.49M
2024Q4
2042
186.55M
93.71%
-18.21M
2024Q3
1986
185.93M
91.29%
-23.02M
2024Q2
1982
190.82M
92.76%
-16.12M
2024Q1
1974
190.22M
92.57%
-13.55M
2023Q4
1991
188.03M
89.99%
-18.28M
2023Q3
1984
188.24M
90.09%
-20.30M
2023Q2
2003
190.89M
91.52%
-16.92M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
23.16M
11.69%
+196.58K
+0.86%
Jun 30, 2025
Dodge & Cox
22.10M
11.15%
+2.01M
+10.01%
Jun 30, 2025
T. Rowe Price Associates, Inc.
14.50M
7.32%
+336.36K
+2.37%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
10.93M
5.52%
-195.19K
-1.75%
Jun 30, 2025
State Street Investment Management (US)
8.75M
4.42%
-6.59K
-0.08%
Jun 30, 2025
Capital International Investors
6.77M
3.42%
+6.77M
--
Jun 30, 2025
American Century Investment Management, Inc.
5.71M
2.88%
+458.90K
+8.74%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.12M
2.59%
+69.48K
+1.37%
Jun 30, 2025
PRIMECAP Management Company
4.71M
2.38%
+27.86K
+0.59%
Jun 30, 2025
Franklin Mutual Advisers, LLC
4.02M
2.03%
+626.52K
+18.47%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Mon, Oct 6
Aktualisiert: Mon, Oct 6
Name
Anteil
Langar Global HealthTech ETF
4.49%
VanEck Morningstar Wide Moat Value ETF
4.46%
Leatherback Long/Short Alternative Yield ETF
3.08%
First Trust Health Care Alphadex Fund
2.5%
VanEck Morningstar Wide Moat ETF
2.47%
iShares U.S. Medical Devices ETF
2.41%
American Century Focused Large Cap Value ETF
2.31%
Invesco Bloomberg Pricing Power ETF
2.15%
SPDR S&P Health Care Equipment ETF
2.03%
First Trust Indxx Medical Devices ETF
1.89%
Mehr Anzeigen
Langar Global HealthTech ETF
Anteil4.49%
VanEck Morningstar Wide Moat Value ETF
Anteil4.46%
Leatherback Long/Short Alternative Yield ETF
Anteil3.08%
First Trust Health Care Alphadex Fund
Anteil2.5%
VanEck Morningstar Wide Moat ETF
Anteil2.47%
iShares U.S. Medical Devices ETF
Anteil2.41%
American Century Focused Large Cap Value ETF
Anteil2.31%
Invesco Bloomberg Pricing Power ETF
Anteil2.15%
SPDR S&P Health Care Equipment ETF
Anteil2.03%
First Trust Indxx Medical Devices ETF
Anteil1.89%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
996.70M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Aug 29, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2024 going ex on Sep 30, 2024 with reinvestment option
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 13, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2024 going ex on Jun 26, 2024 with reinvestment option
Jun 26, 2024
Jul 31, 2024
Jun 26, 2024
Feb 21, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 14, 2023
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 31, 2024
Dec 26, 2023
Aug 25, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2023 going ex on Sep 28, 2023 with reinvestment option
Sep 29, 2023
Oct 31, 2023
Sep 28, 2023
May 15, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2023 going ex on Jun 23, 2023 with reinvestment option
Jun 26, 2023
Jul 31, 2023
Jun 23, 2023
Mar 08, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 28, 2023 going ex on Mar 28, 2023
Mar 29, 2023
Apr 28, 2023
Mar 28, 2023
Dec 15, 2022
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2023 going ex on Dec 23, 2022
Dec 27, 2022
Jan 31, 2023
Dec 23, 2022
Aug 26, 2022
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 31, 2022
Sep 29, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
